1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Unresectable Cholangiocarcinoma: new trials by email Literature Review of Unresectable Cholangiocarcinoma trials Research Report on Unresectable Cholangiocarcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma Pemigatinib, Gemcitabine, Cisplatin - Unresectable Cholangiocarcinoma, Metastatic Cholangiocarcinoma | Phase 3 | Terminated | Incyte Corporation | 167 | 2019-06-03 | 2026-08-11 |
Adenocarcinoma (1) · Carcinoma (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Glandular and Epithelial (1)
Cisplatin (1) · Gemcitabine (1) · pemigatinib (1)
Austria (1) · Belgium (1) · Canada (1) · China (1) · Denmark (1) · Finland (1) · France (1) · Germany (1) · Ireland (1) · Israel (1) · Italy (1) · Japan (1) · Netherlands (1) · Norway (1) · Spain (1)
2018 (1)